Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

14.20
Delayed Data
As of Mar 24
 -0.02 / -0.14%
Today’s Change
11.25
Today|||52-Week Range
19.62
+2.68%
Year-to-Date

Today’s Trading

Previous close14.22
Today’s open14.25
Day’s range14.13 - 14.51
Volume889,023
Average volume (3 months)793,926
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-4.14%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book9.41

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.16+1.08%
PBYIPuma Biotechnology I...-0.40-1.00%
SUPNSupernus Pharmaceuti...+1.55+5.46%
AERIAerie Pharmaceutical...+0.25+0.55%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts


Search for Jobs